Friday, May 1, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Financial Markets

How Medicare Advantage Plans Game the System

Two words: coding density

Jay K Joshi by Jay K Joshi
March 16, 2024
in Financial Markets
0
How Medicare Advantage Plans Game the System

Markus Spiske

Medicare Advantage plans have been a topic of discussion for quite some time now. These plans, also known as Medicare Part C, are offered by private insurance companies and provide an alternative to traditional Medicare. They often offer additional benefits and lower out-of-pocket costs for beneficiaries. However, there is concern about how these plans manipulate Medicare reimbursements. Many plans enjoyed undue astronomical profits in recent years, raising the ire of regulators. Many media outlets and politicians, while complaining about this, fail to understand how Medicare Advantage plans are able to manipulate the reimbursements.

To understand this issue, we first need to understand the concept of coding density of superbills. Superbills are documents used by healthcare providers to record the services they provide to patients. These documents contain codes that represent specific medical procedures, tests, and treatments performed. When a provider submits a claim for reimbursement to Medicare, the coding on the superbills determines the amount of payment they receive.

Medicare Advantage plans have been accused of intentionally adjusting the coding density on superbills to maximize their reimbursement from Medicare. By selectively coding for more complex and higher-paying services, these plans can receive higher reimbursements from Medicare. This practice is especially prevalent in the coding of risk-adjustment factors, which are used to determine the health status and expected costs of the Medicare population.

One way that Medicare Advantage plans manipulate coding density is through a practice known as upcoding. Upcoding occurs when these plans assign a higher-value code to a service or procedure than is medically necessary for the patient’s condition. This tactic allows the plan to receive higher reimbursements for the provided services, ultimately resulting in increased profits. However, the problem with upcoding lies in the fact that it can lead to overpayments by Medicare and, consequently, higher healthcare costs for everyone involved.

In addition to upcoding, Medicare Advantage plans also employ another tactic called cherry-picking patients. By selectively enrolling healthier beneficiaries, who are less likely to require expensive medical services, these plans can artificially inflate their reimbursement rates. By avoiding individuals with chronic illnesses or complex healthcare needs, Medicare Advantage plans can significantly reduce their costs and increase their profits. However, this practice raises concerns about equity and fairness in the healthcare system, as it potentially leaves out individuals who may benefit the most from comprehensive and specialized care.

Both upcoding and cherry-picking patients are controversial practices within the Medicare Advantage landscape. While they may result in financial gains for the plans, they also raise ethical concerns and contribute to higher healthcare costs for consumers and taxpayers. It is essential for policymakers and regulators to address these issues and implement measures that promote transparency, fairness, and the best interests of patients and the healthcare system as a whole.

The manipulation of coding density not only affects Medicare’s reimbursement rates but also has significant implications for patient care. Providers may be incentivized to perform unnecessary services or tests in order to generate higher reimbursements, which can lead to overutilization of healthcare resources. Additionally, upcoding and cherry-picking patients can contribute to disparities in access to care, as sicker individuals may be left with fewer options and higher out-of-pocket costs.

The manipulation of Medicare reimbursements by adjusting the coding density of superbills is an ongoing issue within Medicare Advantage plans. This practice not only impacts the reimbursement rates for these plans but also has implications for patient care and healthcare costs. Regulators must continue monitoring and implementing measures to prevent fraudulent coding practices and ensure that Medicare beneficiaries receive high-quality, appropriate care.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Joshi is the founding editor of Daily Remedy.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape

    Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape

    0 shares
    Share 0 Tweet 0
  • Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.

    0 shares
    Share 0 Tweet 0
  • The Importance of Access Control in the Workplace

    0 shares
    Share 0 Tweet 0
  • State Regulators and the Federal Data Gap: How MedPricer Fills What CMS Leaves Incomplete

    0 shares
    Share 0 Tweet 0
  • Original Sourcing in Health Journalism Is Broken. Price Data Might Help.

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy